A New Fusion Peptide Targeting Pancreatic Cancer and Inhibiting Tumor Growth

BACKGROUND: Pancreatic cancer is a highly malignant tumor of the digestive system. Early pancreatic cancer is often difficult to diagnosis due to its atypical clinical symptoms. Patients with pancreatic cancer have a very poor prognosis because they have lost the opportunity for radical surgical tum...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Lei, Zhang, Bo, He, Xiaoman, Cao, Guodong, Li, Yongzhou, Cai, Kailun, Yang, Bin, Wu, Yulian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434629/
https://www.ncbi.nlm.nih.gov/pubmed/32884283
http://dx.doi.org/10.2147/OTT.S246969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434629/
https://www.ncbi.nlm.nih.gov/pubmed/32884283
http://dx.doi.org/10.2147/OTT.S246969

Ejemplares similares